Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2014 | 7.49 Million USD | 4.95% |
| 2013 | 7.14 Million USD | -12.98% |
| 2012 | 8.2 Million USD | -3.49% |
| 2011 | 8.5 Million USD | 0.43% |
| 2010 | 8.46 Million USD | 22.55% |
| 2009 | 6.9 Million USD | -49.03% |
| 2008 | 13.55 Million USD | 188.51% |
| 2007 | 4.69 Million USD | -12.34% |
| 2006 | 5.36 Million USD | 92.74% |
| 2005 | 2.78 Million USD | 10.8% |
| 2004 | 2.51 Million USD | 31.36% |
| 2003 | 1.91 Million USD | 184.56% |
| 2002 | 671.5 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2015 Q1 | 8.02 Million USD | 7.04% |
| 2015 Q3 | 7.85 Million USD | -1.3% |
| 2015 Q2 | 7.95 Million USD | -0.81% |
| 2014 Q3 | 7.21 Million USD | 3.92% |
| 2014 Q4 | 7.49 Million USD | 3.87% |
| 2014 FY | 7.49 Million USD | 4.95% |
| 2014 Q1 | 6.93 Million USD | -2.85% |
| 2014 Q2 | 6.94 Million USD | 0.08% |
| 2013 Q4 | 7.14 Million USD | -11.7% |
| 2013 Q3 | 8.08 Million USD | 2.36% |
| 2013 Q2 | 7.9 Million USD | 0.55% |
| 2013 Q1 | 7.85 Million USD | -4.25% |
| 2013 FY | 7.14 Million USD | -12.98% |
| 2012 FY | 8.2 Million USD | -3.49% |
| 2012 Q1 | 8.6 Million USD | 1.21% |
| 2012 Q3 | 8.84 Million USD | 0.0% |
| 2012 Q4 | 8.2 Million USD | -7.22% |
| 2011 Q2 | 8.48 Million USD | 1.1% |
| 2011 Q4 | 8.5 Million USD | 0.06% |
| 2011 Q3 | 8.49 Million USD | 0.19% |
| 2011 Q1 | 8.39 Million USD | -0.91% |
| 2011 FY | 8.5 Million USD | 0.43% |
| 2010 Q1 | 7.14 Million USD | 3.44% |
| 2010 FY | 8.46 Million USD | 22.55% |
| 2010 Q4 | 8.46 Million USD | 7.85% |
| 2010 Q3 | 7.85 Million USD | 5.96% |
| 2010 Q2 | 7.41 Million USD | 3.68% |
| 2009 Q1 | 28.31 Million USD | 108.88% |
| 2009 FY | 6.9 Million USD | -49.03% |
| 2009 Q2 | 13.31 Million USD | -52.98% |
| 2009 Q4 | 6.9 Million USD | 0.0% |
| 2008 Q2 | 11.48 Million USD | 3.45% |
| 2008 Q1 | 11.1 Million USD | 136.25% |
| 2008 Q3 | 11.94 Million USD | 4.06% |
| 2008 Q4 | 13.55 Million USD | 13.45% |
| 2008 FY | 13.55 Million USD | 188.51% |
| 2007 Q4 | 4.69 Million USD | 89.7% |
| 2007 FY | 4.69 Million USD | -12.34% |
| 2007 Q1 | 5.73 Million USD | 7.08% |
| 2007 Q2 | 2.34 Million USD | -59.07% |
| 2007 Q3 | 2.47 Million USD | 5.43% |
| 2006 Q3 | 4.38 Million USD | 53.44% |
| 2006 FY | 5.36 Million USD | 92.74% |
| 2006 Q1 | 2.89 Million USD | 4.11% |
| 2006 Q4 | 5.36 Million USD | 22.26% |
| 2006 Q2 | 2.85 Million USD | -1.32% |
| 2005 Q1 | 2.53 Million USD | 1.06% |
| 2005 FY | 2.78 Million USD | 10.8% |
| 2005 Q3 | 3.28 Million USD | 15.91% |
| 2005 Q4 | 2.78 Million USD | -15.39% |
| 2005 Q2 | 2.83 Million USD | 11.79% |
| 2004 Q3 | 2.95 Million USD | -11.28% |
| 2004 FY | 2.51 Million USD | 31.36% |
| 2004 Q2 | 3.33 Million USD | 31.85% |
| 2004 Q1 | 2.52 Million USD | 32.22% |
| 2004 Q4 | 2.51 Million USD | -15.07% |
| 2003 Q2 | 1.22 Million USD | 62.16% |
| 2003 Q4 | 1.91 Million USD | 15.88% |
| 2003 Q1 | 757.97 Thousand USD | 12.88% |
| 2003 Q3 | 1.64 Million USD | 34.16% |
| 2003 FY | 1.91 Million USD | 184.56% |
| 2002 Q3 | 972.92 Thousand USD | 0.0% |
| 2002 FY | 671.5 Thousand USD | 0.0% |
| 2002 Q4 | 671.5 Thousand USD | -30.98% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -107.777% |
| Atlantic International Corp. | 3.82 Million USD | -95.804% |
| Biocept, Inc. | 22.01 Million USD | 65.945% |
| Bioqual, Inc. | 18.93 Million USD | 60.415% |
| CardioGenics Holdings Inc | 1.79 Million USD | -317.655% |
| DermTech, Inc. | 64.75 Million USD | 88.423% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 98.98% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 39.475% |
| iMD Companies, Inc. | 1.67 Million USD | -347.767% |
| IDenta Corp. | 1.01 Million USD | -639.923% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 73.376% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -2416.083% |
| InVitro International | 78.99 Thousand USD | -9390.56% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 62.002% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -5697.964% |
| Medical Imaging Corp. | 9.51 Million USD | 21.23% |
| NovelStem International Corp. | 4.2 Million USD | -78.232% |
| Optigenex Inc. | 9.57 Million USD | 21.671% |
| PharmChem, Inc. | 558.64 Thousand USD | -1241.919% |
| Proteome Sciences plc | 18.48 Million USD | 59.454% |
| Response Genetics, Inc | 15.86 Million USD | 52.754% |
| Rennova Health, Inc. | 49.66 Million USD | 84.906% |
| RushNet, Inc. | 6.23 Million USD | -20.157% |
| ScreenPro Security Inc. | 1.6 Million USD | -368.365% |
| Stella Diagnostics Inc. | 18 Million USD | 58.365% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 8.623% |
| Todos Medical Ltd. | 50.15 Million USD | 85.054% |